{"nct_id":"NCT03626545","title":"Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy","status":"TERMINATED","status_verified_date":"2023-08","start_date":"2019-01-23","start_date_type":"ACTUAL","primary_completion_date":"2021-01-08","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}